Email
Print
Auto Injectors Market Overview
Auto Injectors Market size is estimated at $45.4 billion in 2020, projected to grow at a CAGR of 17.4% during the forecast period 2021-2026. An auto-injector is a small pen-shaped device with a hypodermic needle that is used to administer a set dosage of medication to patients. The medicine is administered by placing the prefilled syringe hypodermic needle in the appropriate injection site and pressing a button. The optimal route of administration is intramuscular, but the location of injection is normally determined by the nature of the medication to be administered. Epinephrine auto-injectors are often used for people who are at risk of anaphylaxis.
In the military, auto-injectors are
often used to shield personnel from chemical weapons agents. The rising
prevalence of multiple sclerosis (MS) is driving the Auto Injectors industry.
According to a report released in February 2019 in the journal Neurology by the
National MS Society, almost 1 million adults in the United States had MS in
2017. The majority of these auto-injector systems are prefilled, spring-loaded prefilled
syringes, hypodermic needle that are used to treat severe allergic reactions
such as anaphylaxis or anaphylactic shock, as well as rheumatoid arthritis and
multiple sclerosis. Auto-Injectors are simple to use and are designed for
patients or other caretakers or staff to administer themselves at home through
various route of administration like Intramuscular
and Subcutaneous.
Auto Injectors Market Report Coverage
The report: “Auto Injectors Market Forecast (2021-2026)”,
by Industry ARC, covers an in-depth analysis of the following segments of the Auto Injectors Market.
By Type: Disposable and Reusable
- Prefilled Auto Injectors and Empty Auto Injectors.
By Disease
Indication: Multiple Sclerosis, Anaphylaxis, Rheumatoid Arthritis,
Diabetes and Cardiovascular Diseases.
By Route of
Administration: Intramuscular and Subcutaneous.
By End Use: Hospitals/Clinics,
Ambulatory Surgical Centers and Homecare.
By
Geography: North America
(U.S, Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and
Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia &
New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and
Rest of South America) and RoW (Middle East and Africa).
Key Takeaways
- Owing to new formulations and drug delivery systems, as well as innovation and advances in the biological drugs, the demand for Auto Injectors is growing thereby, driving the market growth.
- Geographically, North America Auto Injectors Market held the largest revenue share of 39% in 2020 owing to the involvement of potential players who are developing innovative products, advances in medical device technology, high investments in R&D and support of government. In the final report, the scope of the Auto Injectors Market for various regions will be given.
- The Auto Injectors Industry is expanding owing to enhanced R&D efforts by companies to develop quick, cost-effective, and new technology-based auto injectors for the treatment of chronic diseases such as rheumatoid arthritis and multiple sclerosis.
- The factors driving the growth of the Auto Injectors Industry globally are rising self-medication activities, the demand for tailored drug delivery systems for the treatment of chronic diseases, and government reimbursements and marketing approvals for auto-injectors.
Auto Injectors Market: Market Share (%) by Region, 2020
For More Details on This Report - Request for Sample
Auto Injectors Market Segment Analysis By Type:
Based on Type, Auto
Injectors Market is segmented into Disposable and Reusable – Prefilled Auto
Injectors and Empty Auto Injectors. Disposable accounted
for the largest revenue market share in 2020 owing towards increased patient
awareness and propensity toward self-administration, growing demand for
auto-injectors due to rising prevalence of anaphylaxis and other emergency
conditions, hypodermic needle, and easy-to-use disposable auto-injectors. The ease
of use and the availability of a built-in glass prefilled syringe (which
removes the need to manually fill the glass prefilled syringe), disposable auto
injectors is used among patients with decreased dexterity or visual impairments
driving the segment growth. Reusable segment
is anticipated to grow with the fastest CAGR of 17.9% in the forecast period
2021-2026 as it minimizes both manufacturers and patient’s storage and waste
footprints, lowering environmental effects thereby, driving the Auto Injectors Industry.
Auto Injectors Market Segment Analysis – Application:
Based on
Application, Auto Injectors Market is segmented into Multiple
Sclerosis, Anaphylaxis, Rheumatoid Arthritis, Diabetes and Cardiovascular
Diseases. Rheumatoid Arthritis accounted
for the largest revenue market share in 2020. In 2019, the demand for auto injectors
was dominated by rheumatoid arthritis. The high prevalence of this category
accounts for large share. According to the CDC, arthritis, RA, gout, lupus,
and fibromyalgia affect an estimated 43.7 million people (22.7 percent of the
total population) in the United States each year. The demand is growing due to
an increase in the occurrence of anaphylactic shock, as well as government
support for allowing the instrument to be sold in different locations, resulting
in Auto Injectors Industry growth. Multiple Sclerosis segment is anticipated to
grow with the fastest CAGR of 18.1% during the forecast period 2021-2026. Although
there is no cure for MS, general treatment focuses on a quick recovery from
injury, which slows disease progression and manages MS symptoms. The growing
demand for better multiple sclerosis hypodermic needle auto injector options
would result in manufacturers introducing new products into the market,
which boost demand, as well as rising government measures, thereby,
expanding the Auto Injectors Market.
Auto Injectors Market Segment Analysis - By Geography:
Based on Geography, North America Auto Injectors Market accounted for the 39%
revenue share in 2020 owing towards the rising prevalence of anaphylaxis and
food allergies, as well as rapid technical advances in the healthcare field in
this region. According to the American Academy of Pediatrics, almost 5.6
million children in the United States had food allergies in 2018, with less
than half having access to an epinephrine hypodermic needle auto-injector
prescription. Milk, peanut butter, and shellfish are the most common food
allergies. The high prevalence of cardiovascular diseases, especially in the
United States, will provide numerous opportunities for companies operating in
this region to expand. The major players are working on modern Auto Injectors
systems that are technologically advanced. According to the World Health
Organization (WHO), an estimated 26 million people in the United States
suffered from allergies, and an estimated 400,000 people in the United States
and 2.5 million people worldwide suffered from multiple sclerosis in 2015, with
over 400 new cases of multiple sclerosis being found per week in the United
States, according to Healthline Networks, is accelerating Auto Injectors
Industry expansion across the region. Asia-Pacific is predicted to be the
fastest growing region during the forecast period 2021- 2026 owing towards the
large diabetes population and increasing healthcare expenditure.
Auto Injectors Market Drivers
The Increasing Prevalence Of Anaphylaxis:
The market is anticipated to
develop owing the rising incidences of Anaphylaxis. Anaphylaxis reactions
affect one in every 1,000 people, according to a NICE report. During general anaesthesia,
anaphylaxis occurs in 1 in 10,000–20,000 anaesthetics. If a safe combination of
drugs can be found, these patients will be refused general anaesthesia in the
future. Anaphylaxis has an annual occurrence rate of 1.5–50 per 100,000
person-years, according to epidemiological studies. According to a 2019 report reported
in the European Journal of Allergy and Clinical Immunology, the global
incidence of anaphylaxis in children ranged from 1 to 761 per 100,000
person-years for overall anaphylaxis and 1 to 77 per 100,000 person-years for
food-related anaphylaxis. For anaphylaxis, pharmaceutical companies are
developing technologically advanced epinephrine hypodermic needle auto
injectors (EAIs), aiding growth towards the Auto Injectors Industry.
Auto Injectors Market Challenges
Advancement Of Auto Injectors For Multiple Drug Viscosities:
OEMs face the most difficult task in designing
single-design auto injectors for a variety of drugs and biologics with varying
viscosities. To produce a spring rate that provides enough power to push
higher-viscosity drugs and biologics through the prefilled syringe to the hypodermic
needle, springs with different physical characteristics such as structure,
length, and thickness are needed. Many pharmaceutical companies currently lack
the expertise needed to develop auto injectors that can deliver multiple drugs
and biologics with varying viscosities are expected to limit the Auto Injectors
industry growth. Since patients with diabetes, rheumatoid arthritis, and growth
hormone deficiency, among other conditions, need weekly injection therapy with auto
injectors, hypodermic needle anxiety is a major stumbling block to market
expansion. Furthermore, the market's growth is expected to be hampered by the
market's strict regulatory environment for auto-injector approval. The U.S. FDA
classifies auto-injectors as class II high-risk medical devices and is subject
to additional control prior to obtaining approval.
Auto Injectors Market Landscape:
The Auto Injectors Market's main strategies include product
launches, mergers and acquisitions, joint ventures, and regional expansion. Auto Injectors Market top 10
companies are Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc.,
Becton, Dickinson and Company, Sanofi, Pfizer, Inc., Mylan N.V., Teva
Pharmaceutical Industries Ltd., Novartis International AG, Bayer AG and Eli
Lilly and Company.
Acquisitions/Product Launches:
- In January, 2021, Eli Lilly and Company acquired Prevail Therapeutics Inc. Prevail's portfolio of clinical-stage and preclinical neuroscience assets will serve as the foundation for Lilly's new gene therapy program, which will be anchored by the company's clinical-stage and preclinical neuroscience assets.
- In April, 2020, Teva Pharmaceutical Industries Ltd launched autoinjector system for the injection of AJOVY® (fremanezumab-vfrm) in U.S. AJOVY is the only anti-CGRP migraine medication with quarterly and monthly subcutaneous dosing options, and is recommended for the prevention of migraine in adults.
Related Reports
Report Code: HCR 0023
Report Code: HCR 0718
1. Auto Injectors Market - Overview
1.1 Definitions and Scope
2. Auto Injectors Market - Executive Summary
2.1 Market Revenue, Market Size and Key Trends
2.2 Key trends by Type
2.3 Key trends by Disease Indication
2.4 Key trends by Geography
3. Auto Injectors Market - Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis– Key Companies
3.3 Market Share Analysis
3.4 Patent Analysis
3.5 Pricing Analysis- Average Selling Price
4. Auto Injectors Market - Startup Companies Scenario Premium
4.1 Key Startup Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Venture Capital and Funding Scenario
5. Auto Injectors Market – Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing Business Index
5.3 Case Studies of Successful Ventures
6. Auto Injectors Market - Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters Five Force Model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Auto Injectors Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Auto Injectors Market – By Type (Market Size –$Million/$Billion)
8.1 Disposable
8.2 Reusable
8.2.1 Prefilled Auto Injectors
8.2.2 Empty Auto Injectors
9. Auto Injectors Market – By Disease Indication (Market Size –$Million/$Billion)
9.1 Multiple Sclerosis
9.2 Anaphylaxis
9.3 Rheumatoid Arthritis
9.4 Diabetes
9.5 Cardiovascular Diseases
10. Auto Injectors Market – By Route Of Administration (Market Size –$Million/$Billion)
10.1 Intramuscular
10.2 Subcutaneous
11. Auto Injectors Market – By End Use (Market Size –$Million/$Billion)
11.1 Hospitals/Clinics
11.2 Ambulatory Surgical Centers
11.3 Homecare
12. Auto Injectors Market - By Geography (Market Size –$Million/$Billion)
12.1 North America
12.1.1 U.S.
12.1.2 Canada
12.1.3 Mexico
12.2 Europe
12.2.1 U.K.
12.2.2 Germany
12.2.3 France
12.2.4 Italy
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Asia-Pacific
12.3.1 China
12.3.2 India
12.3.3 Japan
12.3.4 South Korea
12.3.5 Australia & New Zealand
12.3.6 Rest of Asia-Pacific
12.4 South America
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Rest of South America
12.5 Rest of the World
12.5.1 Middle East
12.5.2 Africa
13. Auto Injectors Market - Entropy
14. Auto Injectors Market – Industry/Segment Competition Landscape Premium
14.1 Market Share Analysis
14.1.1 Global Market Share – Key Companies
14.1.2 Market Share by Region – Key companies
14.1.3 Market Share by Countries – Key Companies
14.1.4 Best Practices for Companies
15. Auto Injectors Market – Key Company List by Country Premium Premium
16. Auto Injectors Market Company Analysis
16.1 Company 1
16.2 Company 2
16.3 Company 3
16.4 Company 4
16.5 Company 5
16.6 Company 6
16.7 Company 7
16.8 Company 8
16.9 Company 9
16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
LIST OF TABLES
1.Global Auto Injectors Market Analysis and Forecast, By Product Type Market 2023-2030 ($M)1.1 By Product Type Market 2023-2030 ($M) - Global Industry Research
1.1.1 Prefilled Auto Injectors Market 2023-2030 ($M)
1.1.2 Fillable Auto Injectors Market 2023-2030 ($M)
2.Global Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2023-2030 ($M)
2.1 By Therapeutic Area Market 2023-2030 ($M) - Global Industry Research
2.1.1 Anaphylaxis Market 2023-2030 ($M)
2.1.2 Multiple Sclerosis Market 2023-2030 ($M)
2.1.3 Rheumatoid Arthritis Market 2023-2030 ($M)
3.Global Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2023-2030 ($M)
3.1 By Distribution Channel Market 2023-2030 ($M) - Global Industry Research
3.1.1 Hospital Pharmacies Market 2023-2030 ($M)
3.1.2 Retail Pharmacies Market 2023-2030 ($M)
3.1.3 Online Pharmacies Market 2023-2030 ($M)
3.1.4 Drug Stores Market 2023-2030 ($M)
4.Global Competition Landscape Market 2023-2030 ($M)
5.Global Auto Injectors Market Analysis and Forecast, By Product Type Market 2023-2030 (Volume/Units)
5.1 By Product Type Market 2023-2030 (Volume/Units) - Global Industry Research
5.1.1 Prefilled Auto Injectors Market 2023-2030 (Volume/Units)
5.1.2 Fillable Auto Injectors Market 2023-2030 (Volume/Units)
6.Global Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2023-2030 (Volume/Units)
6.1 By Therapeutic Area Market 2023-2030 (Volume/Units) - Global Industry Research
6.1.1 Anaphylaxis Market 2023-2030 (Volume/Units)
6.1.2 Multiple Sclerosis Market 2023-2030 (Volume/Units)
6.1.3 Rheumatoid Arthritis Market 2023-2030 (Volume/Units)
7.Global Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2023-2030 (Volume/Units)
7.1 By Distribution Channel Market 2023-2030 (Volume/Units) - Global Industry Research
7.1.1 Hospital Pharmacies Market 2023-2030 (Volume/Units)
7.1.2 Retail Pharmacies Market 2023-2030 (Volume/Units)
7.1.3 Online Pharmacies Market 2023-2030 (Volume/Units)
7.1.4 Drug Stores Market 2023-2030 (Volume/Units)
8.Global Competition Landscape Market 2023-2030 (Volume/Units)
9.North America Auto Injectors Market Analysis and Forecast, By Product Type Market 2023-2030 ($M)
9.1 By Product Type Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Prefilled Auto Injectors Market 2023-2030 ($M)
9.1.2 Fillable Auto Injectors Market 2023-2030 ($M)
10.North America Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2023-2030 ($M)
10.1 By Therapeutic Area Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Anaphylaxis Market 2023-2030 ($M)
10.1.2 Multiple Sclerosis Market 2023-2030 ($M)
10.1.3 Rheumatoid Arthritis Market 2023-2030 ($M)
11.North America Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2023-2030 ($M)
11.1 By Distribution Channel Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Hospital Pharmacies Market 2023-2030 ($M)
11.1.2 Retail Pharmacies Market 2023-2030 ($M)
11.1.3 Online Pharmacies Market 2023-2030 ($M)
11.1.4 Drug Stores Market 2023-2030 ($M)
12.North America Competition Landscape Market 2023-2030 ($M)
13.South America Auto Injectors Market Analysis and Forecast, By Product Type Market 2023-2030 ($M)
13.1 By Product Type Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Prefilled Auto Injectors Market 2023-2030 ($M)
13.1.2 Fillable Auto Injectors Market 2023-2030 ($M)
14.South America Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2023-2030 ($M)
14.1 By Therapeutic Area Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Anaphylaxis Market 2023-2030 ($M)
14.1.2 Multiple Sclerosis Market 2023-2030 ($M)
14.1.3 Rheumatoid Arthritis Market 2023-2030 ($M)
15.South America Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2023-2030 ($M)
15.1 By Distribution Channel Market 2023-2030 ($M) - Regional Industry Research
15.1.1 Hospital Pharmacies Market 2023-2030 ($M)
15.1.2 Retail Pharmacies Market 2023-2030 ($M)
15.1.3 Online Pharmacies Market 2023-2030 ($M)
15.1.4 Drug Stores Market 2023-2030 ($M)
16.South America Competition Landscape Market 2023-2030 ($M)
17.Europe Auto Injectors Market Analysis and Forecast, By Product Type Market 2023-2030 ($M)
17.1 By Product Type Market 2023-2030 ($M) - Regional Industry Research
17.1.1 Prefilled Auto Injectors Market 2023-2030 ($M)
17.1.2 Fillable Auto Injectors Market 2023-2030 ($M)
18.Europe Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2023-2030 ($M)
18.1 By Therapeutic Area Market 2023-2030 ($M) - Regional Industry Research
18.1.1 Anaphylaxis Market 2023-2030 ($M)
18.1.2 Multiple Sclerosis Market 2023-2030 ($M)
18.1.3 Rheumatoid Arthritis Market 2023-2030 ($M)
19.Europe Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2023-2030 ($M)
19.1 By Distribution Channel Market 2023-2030 ($M) - Regional Industry Research
19.1.1 Hospital Pharmacies Market 2023-2030 ($M)
19.1.2 Retail Pharmacies Market 2023-2030 ($M)
19.1.3 Online Pharmacies Market 2023-2030 ($M)
19.1.4 Drug Stores Market 2023-2030 ($M)
20.Europe Competition Landscape Market 2023-2030 ($M)
21.APAC Auto Injectors Market Analysis and Forecast, By Product Type Market 2023-2030 ($M)
21.1 By Product Type Market 2023-2030 ($M) - Regional Industry Research
21.1.1 Prefilled Auto Injectors Market 2023-2030 ($M)
21.1.2 Fillable Auto Injectors Market 2023-2030 ($M)
22.APAC Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2023-2030 ($M)
22.1 By Therapeutic Area Market 2023-2030 ($M) - Regional Industry Research
22.1.1 Anaphylaxis Market 2023-2030 ($M)
22.1.2 Multiple Sclerosis Market 2023-2030 ($M)
22.1.3 Rheumatoid Arthritis Market 2023-2030 ($M)
23.APAC Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2023-2030 ($M)
23.1 By Distribution Channel Market 2023-2030 ($M) - Regional Industry Research
23.1.1 Hospital Pharmacies Market 2023-2030 ($M)
23.1.2 Retail Pharmacies Market 2023-2030 ($M)
23.1.3 Online Pharmacies Market 2023-2030 ($M)
23.1.4 Drug Stores Market 2023-2030 ($M)
24.APAC Competition Landscape Market 2023-2030 ($M)
25.MENA Auto Injectors Market Analysis and Forecast, By Product Type Market 2023-2030 ($M)
25.1 By Product Type Market 2023-2030 ($M) - Regional Industry Research
25.1.1 Prefilled Auto Injectors Market 2023-2030 ($M)
25.1.2 Fillable Auto Injectors Market 2023-2030 ($M)
26.MENA Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2023-2030 ($M)
26.1 By Therapeutic Area Market 2023-2030 ($M) - Regional Industry Research
26.1.1 Anaphylaxis Market 2023-2030 ($M)
26.1.2 Multiple Sclerosis Market 2023-2030 ($M)
26.1.3 Rheumatoid Arthritis Market 2023-2030 ($M)
27.MENA Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2023-2030 ($M)
27.1 By Distribution Channel Market 2023-2030 ($M) - Regional Industry Research
27.1.1 Hospital Pharmacies Market 2023-2030 ($M)
27.1.2 Retail Pharmacies Market 2023-2030 ($M)
27.1.3 Online Pharmacies Market 2023-2030 ($M)
27.1.4 Drug Stores Market 2023-2030 ($M)
28.MENA Competition Landscape Market 2023-2030 ($M)
LIST OF FIGURES
1.US Auto Injectors Market Revenue, 2023-2030 ($M)2.Canada Auto Injectors Market Revenue, 2023-2030 ($M)
3.Mexico Auto Injectors Market Revenue, 2023-2030 ($M)
4.Brazil Auto Injectors Market Revenue, 2023-2030 ($M)
5.Argentina Auto Injectors Market Revenue, 2023-2030 ($M)
6.Peru Auto Injectors Market Revenue, 2023-2030 ($M)
7.Colombia Auto Injectors Market Revenue, 2023-2030 ($M)
8.Chile Auto Injectors Market Revenue, 2023-2030 ($M)
9.Rest of South America Auto Injectors Market Revenue, 2023-2030 ($M)
10.UK Auto Injectors Market Revenue, 2023-2030 ($M)
11.Germany Auto Injectors Market Revenue, 2023-2030 ($M)
12.France Auto Injectors Market Revenue, 2023-2030 ($M)
13.Italy Auto Injectors Market Revenue, 2023-2030 ($M)
14.Spain Auto Injectors Market Revenue, 2023-2030 ($M)
15.Rest of Europe Auto Injectors Market Revenue, 2023-2030 ($M)
16.China Auto Injectors Market Revenue, 2023-2030 ($M)
17.India Auto Injectors Market Revenue, 2023-2030 ($M)
18.Japan Auto Injectors Market Revenue, 2023-2030 ($M)
19.South Korea Auto Injectors Market Revenue, 2023-2030 ($M)
20.South Africa Auto Injectors Market Revenue, 2023-2030 ($M)
21.North America Auto Injectors By Application
22.South America Auto Injectors By Application
23.Europe Auto Injectors By Application
24.APAC Auto Injectors By Application
25.MENA Auto Injectors By Application